FDA News & Notes - Week of January 16, 2012
SILVER SPRING, Md., Jan. 17, 2012 /PRNewswire-USNewswire/ -- Science, public health, and regulatory highlights from the U.S. Food and Drug Administration. Information in this document is designed for credentialed journalists. Release dates and times for items are current as of January 16, 2012.
(Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO)
FDA News & Notes does not contain any regulatory or enforcement actions due to legal limitations.
Meetings, Workshops and Congressional Testimony:
Wednesday, 1/18 - First day of a three-day public meeting of the Tobacco Products Scientific Advisory Committee. On Jan. 18, from 8 a.m. to 1 p.m., the meeting will be closed to permit discussion and review of trade secret and/or confidential commercial information. The meeting will be open to the public on Jan. 18, from 2 p.m. to 5 p.m., on Jan. 19, from 8 a.m. to 5 p.m., and on Jan. 20, from 8 a.m. to 4 p.m. Meeting will be webcast. 9200 Corporate Boulevard, Rockville, Md.
Press Office Contact: Michelle Bolek, 301-796-2973, michelle.bolek@fda.hhs.gov
Friday, 1/20 - The Reproductive Health Drugs Advisory Committee discusses the benefits and risks of New Drug Application 22-139, progesterone gel 8 percent, submitted by Columbia Laboratories Inc. for "reduction of risk of preterm birth in women with short uterine cervical length regardless of other risk factors in the mid-trimester of pregnancy." 8 a.m., 10903 New Hampshire Avenue, Building 31, Room 1503, Silver Spring, Md.
Press Office Contacts: Morgan Liscinsky, 301-796-0397, morgan.liscinsky@fda.hhs.gov
Stephanie Yao, 301-796-0394, stephanie.yao@fda.hhs.gov
FDA Office of Public Affairs Contact Information:
Call or email FDA Office of Public Affairs, 301-796-4540, fdaopa@fda.hhs.gov
List of FDA press officers and beats
More Resources:
FDA News and Events
SOURCE U.S. Food and Drug Administration